Skip to main content

Prostate Cancer

Volume 475: debated on Wednesday 7 May 2008

To ask the Secretary of State for Health pursuant to the answer of 26 February 2008, Official Report, column 1475W, on prostate cancer, in which primary care trust areas (a) local and (b) specialist urology teams did not review new patients presenting with urological cancer using a multi-disciplinary team. (201589)

The information requested is not held by primary care trust area. However, the following tables set out the relevant information by national health service trust area.

Local urology multi-disciplinary teams (MDTs) non-compliant with “Manual for cancer services 2004” measure 2G-114—

“There should be an operational policy for the team whereby it is intended that all new cancer patients will be reviewed by a multi-disciplinary team”—

as reviewed in the first round of the National Cancer Peer Review 2004-07 are as follows.

Trust

Team

Lancashire Teaching Hospitals NHS Trust

MDT—Lancashire Teaching Hospitals

Wrightington, Wigan and Leigh NHS Trust

MDT—Wrightington, Wigan and Leigh

Aintree Hospitals NHS Trust

MDT—Aintree

Wirral Hospital NHS Trust

MDT—Wirral

James Paget Healthcare NHS Trust

MDT—James Paget

Ealing Hospital NHS Trust

MDT—Ealing Hospital

North Middlesex University Hospital NHS Trust

MDT—North Middlesex University Hospital

Royal Free Hampstead NHS Trust

MDT—Royal Free

Guy’s and St. Thomas’ NHS Trust

MDT—Guys and St. Thomas

Milton Keynes General Hospital NHS Trust

MDT—Milton Keynes General

Surrey and Sussex Healthcare NHS Trust

MDT—East Surrey Hospital

East Sussex Hospitals NHS Trust

MDT—Eastbourne

Specialist urology MDTs non-compliant with Manual for cancer services 2004 measure 2G-114—

“There should be an operational policy for the team whereby it is intended that all new cancer patients will be reviewed by a multi-disciplinary team”—

as reviewed in the first round of the National Cancer Peer Review 2004-07 are as follows.

Trust

Team

University College London Hospitals NHS Trust/Royal Free Hospital NHS Trust

MDT—North London Joint Cancer Centre

Plymouth Hospitals NHS Trust

MDT—Plymouth

To ask the Secretary of State for Health pursuant to the answer of 26 February 2008, Official Report, column 1473W, on prostate cancer, what estimate he has made of the number of people who will have prostate cancer in (a) 2011, (b) 2016 and (c) 2021. (201909)

The Department has made the following estimates of the number of new cases of prostate cancer.

New cases (estimate)

2011

29,625

2016

33,026

2021

36,703

To ask the Secretary of State for Health (1) with reference to the answer of 23 March 2007, Official Report, columns 1203-4W, on prostate cancer, whether he has consulted on revised Prostate Cancer Risk Management programme materials; and when he expects a relaunch of the packs to take place; (201912)

(2) pursuant to the answer of 25 February 2008, Official Report, column 1214W, on prostate cancer, whether the Prostate Cancer Risk Management programme was discussed at the meeting with representatives of the Prostate Cancer Charter for Action of 7 November 2007; and if he will make a statement.

I can confirm that the revision of the Prostate Cancer Risk Management programme (PCRMP) was discussed at my meeting with representatives of the Prostate Cancer Charter for Action on 7 November 2007. Subsequently representatives of the Charter have been members of a small group convened by national health service cancer screening programmes to consult on and oversee the revision of the PCRMP materials. This revision is ongoing, and an exercise seeking the views of key stakeholders will take place on the revised materials in May 2008 prior to the relaunch of the PCRMP in June 2008.

To ask the Secretary of State for Health how many people he estimates will die from prostate cancer in (a) 2008, (b) 2011, (c) 2016 and (d) 2021. (201946)